文献速递神经肿瘤小儿神经外科与脑积水

利用病灶图结合临床特征预测儿童小脑缄默综合征

Predicting cerebellar mutism syndrome in children using lesion map combined with clinical features.
PubMed 文献 · J Neurooncol · 2024-09-03

本研究基于北京儿童医院2013年7月至2023年12月收治的197例后颅窝肿瘤患儿,整合病灶-症状映射(LSM)数据与临床因素构建小脑缄默综合征(CMS)预测模型。模型在训练集、验证集及前瞻性队列中均表现出较高预测性能(C指数分别为0.956、0.933、0.892),性别、病理及体素位置为关键预测因子。

要点

  • 共纳入197例后颅窝肿瘤患儿,CMS发生率在训练、验证及前瞻性组间一致。
  • CMS与性别、肿瘤类型、脑积水、脑室旁水肿、手术入路及病理显著相关。
  • 结合LSM体素位置与临床因素的模型预测性能较高,C指数训练0.956、验证0.933、前瞻性0.892。

核心结论

  • 研究建立了一个有效的儿童后颅窝肿瘤患者CMS预测模型,整合了LSM数据与临床因素。
  • 模型的准确性和稳健性提示其可能在临床实践中用于早期CMS风险评估和干预规划。

研究设计与样本

  • 研究为队列分析,纳入2013年7月至2023年12月在北京儿童医院诊断后颅窝肿瘤并接受手术的患儿。
  • 收集临床变量包括性别、手术时年龄、肿瘤特征、脑积水、手术入路和病理。
  • 采用LSM将肿瘤位置与CMS结局关联,使用Lasso回归和逻辑回归进行特征选择和模型构建。
  • 模型性能通过曲线下面积(AUC)和准确性指标评估。

主要发现

  • 研究共纳入197例患者,CMS发生率在训练、验证和前瞻性组间一致。
  • CMS与性别、肿瘤类型、脑积水、脑室旁水肿、手术入路和病理存在显著关联。
  • 结合LSM体素位置数据与临床因素的预测模型表现出高预测性能(C指数:训练0.956,验证0.933,前瞻性0.892)。
  • 性别、病理和体素位置被确定为CMS的关键预测因子。

临床怎么用

  • 作者认为模型的准确性和稳健性提示其可能用于临床实践中早期CMS风险评估和干预规划。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to develop a predictive model for cerebellar mutism syndrome (CMS) in pediatric patients with posterior fossa tumors, integrating lesion-symptom mapping (LSM) data with clinical factors, and to assess the model's performance. METHODS: A cohort of pediatric patients diagnosed with posterior fossa tumors and undergoing surgery at Beijing Children's Hospital from July 2013 to December 2023 was analyzed. Clinical variables gender, age at surgery, tumor characteristics, hydrocephalus, surgical route and pathology were collected. LSM was used to link tumor locations with CMS outcomes. Lasso regression and logistic regression were employed for feature selection and model construction, respectively. Model performance was assessed using area under the curve (AUC) and accuracy metrics. RESULTS: The study included 197 patients in total, with CMS rates consistent across training, validation, and prospective groups. Significant associations were found between CMS and gender, tumor type, hydrocephalus, paraventricular edema, surgical route, and pathology. A predictive model combining voxel location data from LSM with clinical factors achieved high predictive performance (C-index: training 0.956, validation 0.933, prospective 0.892). Gender, pathology, and voxel location were identified as key predictors for CMS. CONCLUSION: The study established an effective predictive model for CMS in pediatric posterior fossa tumor patients, leveraging LSM data and clinical factors. The model's accuracy and robustness suggest its potential utility in clinical practice for early CMS risk assessment and intervention planning.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Yang W, Chai X, Zhang N, et al. Predicting cerebellar mutism syndrome in children using lesion map combined with clinical features. J Neurooncol. 2024. PMID: 39225955. doi:10.1007/s11060-024-04815-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。